TG Therapeutics Inc TGTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/16/21 EDT
44.34quote price arrow down-0.44 (-0.98%)
Volume
76,875
Close
44.78quote price arrow down-1.05 (-2.29%)
Volume
3,746,647
52 week range
9.88 - 56.74

...

Loading . . .
  • Open47.90
  • Day High49.39
  • Day Low44.39
  • Prev Close45.83
  • 52 Week High56.74
  • 52 Week High Date01/13/21
  • 52 Week Low9.88
  • 52 Week Low Date04/15/20

Key Stats

  • Market Cap6.296B
  • Shares Out140.59M
  • 10 Day Average Volume1.09M
  • Dividend-
  • Dividend Yield-
  • Beta2.14
  • YTD % Change-13.92

KEY STATS

  • Open47.90
  • Day High49.39
  • Day Low44.39
  • Prev Close45.83
  • 52 Week High56.74
  • 52 Week High Date01/13/21
  • 52 Week Low9.88
  • 52 Week Low Date04/15/20
  • Market Cap6.296B
  • Shares Out140.59M
  • 10 Day Average Volume1.09M
  • Dividend-
  • Dividend Yield-
  • Beta2.14
  • YTD % Change-13.92

RATIOS/PROFITABILITY

  • EPS (TTM)-2.39
  • P/E (TTM)-18.72
  • Fwd P/E (NTM)-25.53
  • EBITDA (MRQ)-273.436M
  • ROE (MRQ)-100.14%
  • Revenue (MRQ)150,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-183,803.30%
  • Debt To Equity (MRQ)5.94%

EVENTS

  • Earnings Date05/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From TG Therapeutics Inc

Profile

MORE
TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered monoclonal antibody that targets a specific epitope on the cluster of differentiation (CD20) antigen found on mature B-lymphocytes. The Company is...
Michael Weiss J.D.
Chairman
Sean Power CPA
Chief Financial Officer
Kelly Ross
Chief Technology Officer
Address
2 Gansevoort St Fl 9
New York, NY
10014-1667
United States

Top Peers

SYMBOLLASTCHG%CHG
BBIO
BridgeBio Pharma Inc
55.12+0.17+0.31%
ASND
Ascendis Pharma A/S
121.95-2.23-1.80%
PACB
Pacific Biosciences of California Inc
31.53-1.32-4.02%
ARWR
Arrowhead Pharmaceuticals Inc
67.65-0.33-0.49%
KOD
Kodiak Sciences Inc
114.89-0.82-0.71%